Search results for: 'cancer and countir'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs),...

This research service focuses on the market for such therapeutics. It aims to introduce market opportunity for breast cancer therapeutics in the United States, and the top seven markets in Europe (Germany, France, the United Kingdom, Spain, Italy, Benelux and Scandinavia). For the purpose of analysis, a market forecast for the total world breast ca...

The leading cause of cancer deaths in women globally is breast cancer. Regular breast cancer screening is imperative for early detection and timely intervention. Screening mammography is the method most commonly used worldwide for the detection of breast cancer. However, the traditional methods of screening are plagued by several challenges. Over t...

This research service explores the market for therapeutics used for the treatment of breast cancer in the Unites States of America. It analyzes the various challenges faced by pharmaceutical companies, and the competitive advantages and disadvantages of their products in the market.

The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2...

This research service provides the patient outlook and forecast for colorectal cancer in the U.S. from 2003-2013. The patient population is discussed in terms of staging and line of therapy.

This research service analyzes the U.S. cancer biomarker testing market from 2009 to 2017. Topics include an overview of the market, along with definitions, metrics, drivers, and restraints. Also offered is an evaluation of ongoing technology trends and major market competitors and their corresponding market shares and product offerings. Based on t...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...